Role of epithelial integrin-linked kinase in promoting intestinal inflammation: Effects on CCL2, fibronectin and the T cell repertoire

BMC Immunology

Volumn 12, Issue , 2011, Pages

  Assi, Kiran ^a   Patterson, Scott ^a   Dedhar, Shoukat ^b   Owen, David ^a   Levings, Megan ^a   Salh, Baljinder ^a  

^a JACK BELL RESEARCH CENTRE   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

CCL2; Colitis; Fibronectin; ILK; T regulatory cells

Indexed keywords

CYTOKINE; DEXTRAN SULFATE; FIBRONECTIN; GAMMA INTERFERON; INTEGRIN LINKED KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; IMMUNOLOGIC FACTOR; INTEGRIN-LINKED KINASE; LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; INTESTINE EPITHELIUM CELL; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; CELL STRAIN HCT116; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOUSE MUTANT; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CHEMOKINE CCL2; COLITIS; EPITHELIAL CELLS; FEMALE; FIBRONECTINS; GENE EXPRESSION REGULATION; HCT116 CELLS; HUMANS; IMMUNOLOGIC FACTORS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN-SERINE-THREONINE KINASES; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; WEIGHT LOSS;

EID: 79960875630     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-12-42     Document Type: Article

References (32)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-34. 10.1038/nature06005, 17653185.
2. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008, 8:458-66. 10.1038/nri2340, 18500230.
3. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997, 337:1029-35. 10.1056/NEJM199710093371502, 9321530.
4. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007, 369:1641-57. 10.1016/S0140-6736(07)60751-X, 17499606.
5. McDonald PC, Fielding AB, Dedhar S. Integrin-linked kinase - essential roles in physiology and cancer biology. J Cell Sci 2008, 121:3121-32. 10.1242/jcs.017996, 18799788.
6. Hannigan G, Troussard AA, Dedhar S. Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 2005, 5:51-63. 10.1038/nrc1524, 15630415.
7. Fukuda T, Chen K, Shi X, Wu C. PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival. J Biol Chem 2003, 278:51324-33. 10.1074/jbc.M309122200, 14551191.
8. McDonald PC, Oloumi A, Mills J, Dobreva I, Maidan M, Gray V, Wederell ED, Bally MB, Foster LJ, Dedhar S. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res 2008, 68:1618-24. 10.1158/0008-5472.CAN-07-5869, 18339839.
9. Liu E, Sinha S, Williams C, Cyrille M, Heller E, Snapper SB, Georgopoulos K, St-Arnaud R, Force T, Dedhar S, et al. Targeted deletion of integrin-linked kinase reveals a role in T-cell chemotaxis and survival. Mol Cell Biol 2005, 25:11145-55. 10.1128/MCB.25.24.11145-11155.2005, 1316981, 16314534.
10. Assi K, Mills J, Owen D, Ong C, St Arnaud R, Dedhar S, Salh B. Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis. Gut 2008, 57:931-40. 10.1136/gut.2007.142778, 18326560.
11. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995, 109:1344-67. 10.1016/0016-5085(95)90599-5, 7557106.
12. Assi K, Pillai R, Gomez-Munoz A, Owen D, Salh B. The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis. Immunology 2006, 118:112-21. 10.1111/j.1365-2567.2006.02349.x, 1782268, 16630028.
13. Troussard AA, Mawji NM, Ong C, Mui A, St-Arnaud R, Dedhar S. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation. J Biol Chem 2003, 278:22374-8. 10.1074/jbc.M303083200, 12686550.
14. Oloumi A, Syam S, Dedhar S. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells. Oncogene 2006, 25:7747-57. 10.1038/sj.onc.1209752, 16799642.
15. Motomura Y, Khan WI, El-Sharkawy RT, Verma-Gandhu M, Verdu EF, Gauldie J, Collins SM. Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1. Gut 2006, 55:662-70. 10.1136/gut.2005.068429, 1856110, 16299040.
16. Wu C, Keightley SY, Leung-Hagesteijn C, Radeva G, Coppolino M, Goicoechea S, McDonald JA, Dedhar S. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J Biol Chem 1998, 273:528-36. 10.1074/jbc.273.1.528, 9417112.
17. Kolachala VL, Bajaj R, Wang L, Yan Y, Ritzenthaler JD, Gewirtz AT, Roman J, Merlin D, Sitaraman SV. Epithelial-derived fibronectin expression, signaling, and function in intestinal inflammation. J Biol Chem 2007, 282:32965-73. 10.1074/jbc.M704388200, 17855340.
18. Izcue A, Coombes JL, Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 2009, 27:313-38. 10.1146/annurev.immunol.021908.132657, 19302043.
19. Bollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP, Evanko SP, Buckner JH, Wight TN, Nepom GT. CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J Immunol 2009, 183:2232-41. 10.4049/jimmunol.0900191, 3057032, 19635906.
20. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003, 199:28-35. 10.1002/path.1245, 12474223.
21. Khan WI, Motomura Y, Wang H, El-Sharkawy RT, Verdu EF, Verma-Gandhu M, Rollins BJ, Collins SM. Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol 2006, 291:G803-11. 10.1152/ajpgi.00069.2006, 16728728.
22. Andres PG, Beck PL, Mizoguchi E, Mizoguchi A, Bhan AK, Dawson T, Kuziel WA, Maeda N, MacDermott RP, Podolsky DK, et al. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J Immunol 2000, 164:6303-12.
23. Palmieri O, Latiano A, Salvatori E, Valvano MR, Bossa F, Latiano T, Corritore G, di Mauro L, Andriulli A, Annesec V. The -A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease. Am J Gastroenterol 105:1586-94.
24. Hynes RO, George EL, Georges EN, Guan JL, Rayburn H, Yang JT. Toward a genetic analysis of cell-matrix adhesion. Cold Spring Harb Symp Quant Biol 1992, 57:249-58.
25. Brenmoehl J, Lang M, Hausmann M, Leeb SN, Falk W, Scholmerich J, Goke M, Rogler G. Evidence for a differential expression of fibronectin splice forms ED-A and ED-B in Crohn's disease (CD) mucosa. Int J Colorectal Dis 2007, 22:611-23. 10.1007/s00384-006-0188-4, 17136547.
26. Bataille F, Rohrmeier C, Bates R, Weber A, Rieder F, Brenmoehl J, Strauch U, Farkas S, Furst A, Hofstadter F, et al. Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Inflamm Bowel Dis 2008, 14:1514-27. 10.1002/ibd.20590, 18626977.
27. Gagne D, Groulx JF, Benoit YD, Basora N, Herring E, Vachon PH, Beaulieu JF. Integrin-linked kinase regulates migration and proliferation of human intestinal cells under a fibronectin-dependent mechanism. J Cell Physiol 222:387-400.
28. Alon R, Cahalon L, Hershkoviz R, Elbaz D, Reizis B, Wallach D, Akiyama SK, Yamada KM, Lider O. TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. J Immunol 1994, 152:1304-13.
29. Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS, Cua DJ, Powrie F, Cheever AW, Maloy KJ, et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 2006, 203:2485-94. 10.1084/jem.20061082, 2118119, 17030948.
30. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-88. 10.1016/j.immuni.2006.06.002, 16782025.
31. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-3. 10.1126/science.1135245, 17068223.
32. Voo KS, Wang YH, Santori FR, Boggiano C, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci USA 2009, 106:4793-8. 10.1073/pnas.0900408106, 2653560, 19273860.